Equities

Little Green Pharma Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LGP:ASX

Little Green Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.1225
  • Today's Change0.00 / 0.00%
  • Shares traded157.19k
  • 1 Year change-2.00%
  • Beta0.7710
Data delayed at least 20 minutes, as of Feb 11 2026 02:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. Its principal activities include the cultivation of medicinal cannabis, procurement of raw materials and production of medicinal cannabis medicines; the supply of medicinal cannabis products into Australia and Europe; the supply of medicinal cannabis products for observational and clinical studies and research and development of new medicinal cannabis products, and the development of a psychedelics business including sponsoring a clinical trial into the treatment of refractory depression with psilocybin assisted therapy, construction of a psilocybin mushroom cultivation facility, and establishment of a psychedelic treatment clinic. It has a diverse and growing portfolio of cannabis-based medicines, distributed across Australia and over 12 export markets.

  • Revenue in AUD (TTM)38.49m
  • Net income in AUD5.86m
  • Incorporated2016
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LGP:ASX since
announced
Transaction
value
Cannatrek LtdAnnounced14 Jan 202614 Jan 2026Announced2.08%40.71m
Data delayed at least 20 minutes, as of Feb 11 2026 02:10 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Immuron Ltd7.29m-5.22m10.13m7.00--0.8988--1.39-0.0226-0.02260.03160.03450.56751.504.401,041,000.00-40.62-27.84-49.64-30.6065.3970.18-71.58-182.344.19--0.00--48.6323.6724.81------
Tissue Repair Ltd3.02m-4.24m11.49m----0.8258--3.81-0.0701-0.07010.04990.23010.1777--60.84---24.96-24.25-26.50-25.27-----140.49-518.5422.40--0.00--236.85---2.43------
Epsilon Healthcare Ltd6.13m-6.12m12.29m--------2.00-0.0164-0.01640.0167-0.00970.462--4.95---46.14-33.37-156.14-46.4652.2349.34-99.85-136.160.3775-3.921.67---15.813.16-403.56---32.83--
Calmer Co International Ltd8.03m-3.99m13.76m----7.12--1.71-0.0015-0.00150.00290.00061.603.2914.33---79.73-109.82-171.17-197.5042.4941.18-49.69-128.711.22-11.320.5482--88.4859.99-7.13--27.67--
Firebrick Pharma Ltd293.42k-2.63m16.35m----9.38--55.73-0.0126-0.01260.00140.00690.13860.86960.4855---124.44-98.41-143.50-109.2835.72---897.84-5,384.554.75--0.00--1,920.80---124.04------
Oncosil Medical Ltd1.26m-15.10m19.13m2.00--3.32--15.16-1.37-1.370.11480.2170.182--2.18---217.79-97.54-382.54-117.83-78.62-54.05-1,196.80-1,258.41---146.890.022--116.34-15.15-26.74---6.31--
TrivarX Ltd1.13m-943.23k28.84m4.00--1.22--25.46-0.0018-0.00180.00230.02040.0923-------7.68-33.47-8.32-37.46-----83.27-373.85---27.050.0132--26.383.8934.25--6.29--
Avecho Biotechnology Ltd1.38m-3.62m34.90m29.00--36.54--25.28-0.0011-0.00110.00040.00030.21154.461.91---55.49-61.23-72.92-73.2762.2755.45-262.41-382.044.53-8.030.0647--139.19-23.209.15------
Vitura Health Ltd124.04m3.28m36.45m119.0010.190.75566.870.29390.00540.00540.20340.07281.6916.4310.46--4.1112.755.7217.6227.2130.972.436.061.059.500.2009--0.1341298.23-5.35--129.38--
Little Green Pharma Ltd38.49m5.86m37.44m--6.330.43533.860.97270.01940.01940.12680.28140.42620.819914.01--6.48--7.09--67.46--15.21--0.8728-4.710.0541--43.67--140.77------
Next Science Ltd31.12m-13.30m42.43m--------1.36-0.0455-0.04550.1065-0.00272.075.425.69---88.62-72.67-148.75-86.8782.4877.69-42.74-87.991.25-13.181.12--2.8741.2334.94---18.19--
Inoviq Ltd959.32k-6.93m47.16m85.00--2.24--49.16-0.0623-0.06230.00860.14970.04783.730.6725---34.52-43.01-37.36-45.8787.4589.08-722.62-1,543.445.72--0.022--21.1757.69-5.77------
Medical Developments International Ltd39.06m94.00k52.39m68.00553.570.950715.891.340.00080.00080.34690.48910.62211.065.31--0.1497-16.680.1738-18.9275.3572.700.2407-47.083.33--0.0349--17.8211.30100.23-24.33-34.91--
Data as of Feb 11 2026. Currency figures normalised to Little Green Pharma Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.